Clinical Trial Update: HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating hepatic arterial infusion chemotherapy with oxaliplatin, 5-fluorouracil, and bevacizumab in combination with intravenous toripalimab …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• OXALIPLATIN (Oxaliplatin)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Peking University | Conditions: Advanced Biliary Tract Cancer | Phase 2 | Status: COMPLETED